Autoimmunity associated with TGF-β1-deficiency in mice is dependent on MHC class II antigen expression

Journal of Clinical Investigation

Volumn 98, Issue 9, 1996, Pages 2109-2119

  Letterio, John J ^a,e   Geiser, Andrew G ^b   Kulkarni, Ashok B ^c   Dang, Howard ^d   Kong, Liping ^d   Nakabayashi, Toru ^d   Mackall, Crystal L ^a   Gress, Ronald E ^a   Roberts, Anita B ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^d Mays Cancer Center at UT Health San Antonio   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

hematopoiesis; inflammation; leukocyte; metaplasia; myeloid

Indexed keywords

CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CROSSING OVER; DRUG THERAPY; ETIOLOGY; EXTRAMEDULLARY HEMATOPOIESIS; GENOTYPE; HEMATOPOIESIS; HOMOZYGOSITY; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHADENOPATHY; MOUSE; MYELOID METAPLASIA; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SPLENOMEGALY; SURVIVAL; T LYMPHOCYTE;

EID: 0029907123     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119017     Document Type: Article

References (48)

1. Bombara, C., and R. Ignotz. 1992. TGF-beta inhibits proliferation of and promotes differentiation of human promonocytic leukemia cells. J. Cell. Physiol. 153:30-37.
2. Gamble, J.R., Y. Khew-Goodall, and M.A. Vadas. 1993. Transforming growth factor-β inhibits E-selectin expression on human endothelial cells. J. Immunol. 150:4494-4503.
3. Wahl, S.M., J.B. Allen, B.S. Weeks, H.L. Wong, and P.E. Klotman. 1993. Transforming growth factor β enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. USA. 90:4577-4581.
4. Tsunawaki, S., M. Sporn, A. Ding, and C. Nathan. 1988. Deactivation of macrophages by transforming growth factor-β. Nature (Lond.). 334:260-262.
5. Vodovotz, Y., C. Bogdan, J. Paik, Q.-W. Xie, and C. Nathan. 1993. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J. Exp. Med. 178:605-613.
6. McCartney-Francis, N.L., and S.M. Wahl. 1994. Transforming growth factor β: a matter of life and death. J. Leukocyte Biol. 55:401-409.
7. Wahl, S.M. 1992. TGF-β in inflammation. A cause and a cure. J. Clin. Immunol. 12:61-74.
8. Wahl, S.M. 1994. Transforming growth factor β: the good, the bad, and the ugly. J. Exp. Med. 180:1587-1590.
9. Fontana, A., D.B. Constam, K. Frei, U. Malipiero, and H.W. Pfister. 1992. Modulation of the immune response by transforming growth factor beta. Int. Arch. Allergy Immunol. 99:1-7.
10. Letterio, J.J., and A.B. Roberts. 1996. Transforming growth factor-β1-deficient mice: identification of isoform-specific activities in vivo. J. Leukocyte Biol. 59:769-774.
11. Kulkarni, A.B., J.M. Ward, A.G. Geiser, J.J. Letterio, K.L. Hines, M. Christ, R.N. D'Souza, C. Huh, A.B. Roberts, M.B. Sporn, et al. 1994. TGF-β1 knockout mice: immune dysregulation and pathology. In Molecular Biology of Haematopoiesis. N.G. Abraham, R.K Shadduck, A.S. Levine, and F. Takaku, editors. Intercept, Paris. 749-757.
12. Schull, M.M., A.B. Kier, R.J. Diebold, Y. Moying, and T. Doetschman. 1994. The importance of transforming growth factor β1 in immunological homeostasis, as revealed by gene ablation in mice. In Overexpression and Knockout of Cytokines in Transgenic Mice. Academic Press Ltd., London. 135-159.
13. Schull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, B. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature (Lond.). 359:693-699.
14. Kulkarni, A.B., C. Huh, D. Becker, A. Geiser, M. Lyght, K.C. Flanders, A.B. Roberts, M.B. Sporn, J.M. Ward, and S. Karlsson. 1993. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA. 90:770-774.
15. Dang, H., A.G. Geiser, J.J. Letterio, T. Nakabayashi, L. Kong, G. Fernandes, and N. Talal. 1995. SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-β1 knockout mice. J. Immunol. 155: 3205-3212.
16. Geiser, A.G., J.J. Letterio, A.B. Kulkarni, S. Karlsson, A.B. Roberts, and M.B. Sporn. 1993. Transforming growth factor β1 (TGF-β1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-β1 null mouse phenotype. Proc. Natl. Acad. Sci. USA. 90:9944-9948.
17. Christ, M., N.L. McCartney-Francis, A.B. Kulkarni, J.M. Ward, D.E. Mizel, C.L. Mackall, R.E. Gress, K.L. Hines, H. Tian, S. Karlsson, and S.M. Wahl. 1994. Immune dysregulation in TGF-β1-deficient mice. J. Immunol. 153: 1936-1946.
18. Hines, K.L., A.B. Kulkarni, J.B. McCarthy, H. Tian, J.M. Ward, M. Christ, N.L. McCartney-Francis, L.T. Furcht, S. Karlsson, and S. Wahl. 1994. Synthetic fibronectin peptides interrupt inflammatory cell infiltration in transforming growth factor β1 knockout mice. Proc. Natl. Acad. Sci. USA. 91:5187-5191.
19. Diebold, R.J., M.J. Eis, M. Yin, I. Ormsby, G.P. Boivin, B.J. Darrow, J.E. Saffitz, and T. Doetschman. 1995. Early-onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated. Proc. Natl. Acad. Sci. USA. 92:12215-12219.
20. Yaswen, L., A.B. Kulkarni, T. Frederickson, B. Mittleman, R. Schiffmann, S. Payne, G. Longenecker, E. Mozes, and S. Karlsson. 1995. Autoimmune manifestations in the TGF-β1 knockout mouse. Blood. 87:1439-1445.
21. Miller, A., O. Lider, A.B. Roberts, M.B. Sporn, and H.L. Weiner. 1992. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific triggering. Proc. Natl. Acad. Sci. USA. 89: 421-425.
22. Racke, M.K., B. Cannella, P. Albert, M. Sporn, C.S. Raine, and D.E. McFarlin. 1992. Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis. Int. Immunol. 4: 615-620.
23. Lowrance, J.H., F.X. O'Sullivan, T.E. Caver, W. Waegell, and H.D. Gresham. 1994. Spontaneous elaboration of transforming growth factor β suppresses host defense against bacterial infection in autoimmune MRL/lpr mice. J. Exp. Med. 180:1693-1703.
24. Racke, M.K., S. Dhib-Jalbut, B. Cannella, P.S. Albert, C.S. Raine, and D.E. McFarlin. 1991. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J. Immunol. 146:3012-3017.
25. Brandes, M.E., J.B. Allen, Y. Ogawa, and S.M. Wahl. 1991. Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J. Clin. Invest. 87:1108-1113.
26. Sinha, A.A., T. Lopez, and H.O. McDevitt. 1990. Autoimmune diseases: the failure of self tolerance. Science (Wash. DC). 248:1380-1388.
27. Grusby, M.J., R.S. Johnson, V.E. Papaioannou, and L.H. Glimcher. 1991. Depletion of CD4+ T cells in major histocompatihility complex II-deficient mice. Science (Wash. DC). 253:1417-1420.
28. Dialynas, D.P., Z.S. Quan, K.A. Wall, A. Pierres, J. Quintans, M.R. Loken, M. Pierres, and F.W. Fitch. 1983. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J. Immunol. 131:2445-2450.
29. +) subsets among anti-Ia cytolytic T cell clones. J. Immunol. 132:2775-2782.
30. Tan, E.M. 1982. Autoantibodies to nuclear antigens: their immunobiology and medicine. Adv. Immunol. 33:167-172.
31. Eisenberg, R.A., S.Y. Craven, R.W. Warren, and P.L. Cohen. 1987. Stochastic control of anti-Sm autoantibodies in MRL/Mp-lpr/lpr mice. J. Clin. Invest. 80:691-697.
32. Boivin, G.P., B.A. O'Toole, I.E. Orsmby, R.J. Diebold, M.J. Eis, T. Doetschman, and A.B. Kier. 1995. Onset and progression of pathological lesions in transforming growth factor-β1-deficient mice. Am. J. Pathol. 146:276-288.
33. Wofsy, D., J.A. Ledbetter, P.L. Hendler, and W.E. Seaman. 1985. Treatment of murine lupus with monoclonal anti-T cell antibody. J. Immunol. 134: 852-859.
34. Wofsy, D., and W.E. Seaman. 1985. Successful treatment of autoimmunity in NZB/NZW F1 mice with monoclonal antibody to L3T4. J. Exp. Med. 161:378-391.
35. Ranges, G.E., S. Sriram, and S.M. Cooper. 1985. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J. Exp. Med. 162:1105-1112.
36. Sobel, R.A., B.W. Blanchette, A.K. Bhan, and R.B. Colvin. 1984. The immunopathology of acute experimental allergic encephalomyelitis. II. Endothelial cell Ia expression increases prior to inflammatory cell infiltration. J. Immunol. 132:2402-2407.
37. Khoury, S.J., W.W. Hancock, and H.L. Weiner. 1992. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin E expression in the brain. J. Exp. Med. 176:1355-1364.
38. Reimold, A.M., C.J. Kara, J.W. Rooney, and L.H. Glimcher. 1993. Transforming growth factor β1 repression of the HLA-DRa gene is mediated by conserved proximal promoter elements. J. Immunol. 151:4173-4182.
39. Jameson, B.A., J.M. McDonnell, J.C. Marini, and R. Korngold. 1994. A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature (Lond.). 368:744-746.
40. Hilbert, D.M., M.-Y. Shen, U.R. Rapp, and S. Rudikoff. 1995. T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors. Proc. Natl. Acad. Sci. USA. 92:649-653.
41. Waegell, W.O., H.R. Higley, P.W. Kincade, and J.R. Dasch. 1994. Growth acceleration and stem cell expansion in Dexter-type cultures by neutralization of TGF-β. Exp. Hematol. 22:1051-1057.
42. Jacobsen, S.E., J.R. Keller, F.W. Ruscetti, P. Kondaiah, A.B. Roberts, and L.A. Falk. 1991. Bidirectional effects of transforming growth factor-β (TGF-β) on colony-stimulating factor-induced human myelopoiesis in vitro: differential effects of distinct TGF-β isoforms. Blood. 78:2239-2245.
43. Carlino, J.A., H.R. Higley, J.R. Creson, P.D. Avis, and Y. Ogawa. 1992. Transforming growth factor-β1 systematically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice. Exp. Hematol. 20:943-949.
44. Heinrich, M.C., D.C. Dooley, and W.W. Keeble. 1995. Transforming growth factor β1 inhibits expression of the gene products for steel factor and its receptor (c-kit). Blood. 85:1769-1780.
45. Jacobsen, S.E., F.W. Ruscetti, A.B. Roberts, and J.R. Keller. 1993. TGF-β is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. Differential effects of TGF-β1 and TGF-β3. J. Immunol. 151:4534-4539.
46. Deeg, H.J., C. Beckham, R. Huss, D. Myerson, H. Greinix, F.R. Appelbaum, T. Graham, F. Schuening, and R. Storb. 1994. Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand. Blood. 83:2352-2359.
47. Greinix, H.T., R. Storb, and S.H. Bartelmez. 1992. Specific growth inhibition of primitive hematopoietic progenitor cells mediated through monoclonal antibody binding to major histocompatibility class II molecules. Blood. 80:1950-1956.
48. Torok-Storb, B., and J.A. Hansen. 1982. Modulation of in vitro BFU-E growth by normal Ia-positive T cells is restricted by HLA-DR. Nature (Lond.). 298:473-478.